Synopsis
The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
Programme
Day 1 - 13 June 2016
- 08:30
- Registration and refreshments
- 09:20
- Opening remarks Jonathan Goldman, Aptuit, and an Organising Committee member
- 09:30
- Plenary: The seventh millennium of GPCR drug discovery Fiona Marshall, Heptares Therapeutics, UK
- 10:20
- Insights into chemistry and biology of GPCRs from molecular modelling Irina Tikhonova, Queen's University Belfast, UK
- 10:55
- Refreshments and exhibition
- 11:25
- Biased agonism @ FPR2 Olivier Corminboeuf, Actelion, Switzerland
- 1200
- TAAR1 agonists – a new approach for the treatment of psychiatric disorders Roger Norcross, Roche Pharma Research & Early Development, Switzerland
- 12:30
- Binding of anticholinergics to the M3 receptor: explaining kinetics by mutagenesis and molecular dynamics simulations Christofer Tautermann, Boehringer Ingelheim, Switzerland
- 13:00
- Lunch and exhibition
- 14:00
- Design, synthesis and pharmacological profile of the GPR40 receptor agonist MK-8666 Ravi Nargund, Merck, USA
- 14:40
- High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 Gyorgy Snell, Takeda California, USA
- 15:10
- Refreshments and exhibition
- 15:40
- Universal mechanism of activation of G proteins by GPCRs Madan Babu, Medical Research Council LMB, UK
- 16:25
- Close
- 16:30
- Coaches depart for visit to Vineyard (Cantina Sociale di Soave - Soave and Valpolicella) and evening meal
- 20:00
- Coaches leave Vineyard for Verona city centre
Day 2 - 14 June 2016
- 09:30
- Recent computational trends in exploring G protein-coupled receptor (GPCR) ligand recognition pathways Stefano Moro, University of Padova, Italy
- 10:00
- Discovery of small molecule modulators of PAR–2 Roland Bürli, AstraZeneca and MedImmune, UK
- 10:30
- Refreshments, exhibition and posters
- 11:00
- Nutrient sensing GPCR FFAR1 (GPR40): allosteric agonist binding mode and physical properties influence agonist pharmacology Bruce Ellsworth, Bristol-Myers Squibb, USA
- 11:30
- Roles of waters to predict binding affinity, selectivity and kinetics: a key component of high end GPCR SBDD Jonathan Mason, Heptares Therapeutics, UK
- 12:15
- Lunch, exhibition and posters
- 13:15
- Design and synthesis of highly selective 5-HT2C receptor agonists as potential novel treatment for neuropsychiatric diseases Andreas Haupt, AbbVie, Germany
- 13:50
- Dopamine D3/D2 antagonist PF-04363467 attenuates drug-seeking behaviour without concomitant D2 side effects Travis Wager, Pfizer, USA
- 14:25
- Discovery of mGluR2 negative allosteric modulators for the treatment of neuropsychiatric disorders Speaker to be confirmed, Janssen, Belgium
- 15:00
- Refreshments, exhibition and posters
- 15:30
- Acquired resistance to smoothened inhibitors in cancer patients Hayley Sharpe, Genentech, USA
- 16:05
- Plenary: How many GPCR structures do we need? Vsevolod (Seva) Katritch, University of South California, USA
- 16:55
- Flash poster presentations
- 17:30
- Poster session
- 19:00
- Conference dinner at Aptuit
Day 3 - 15 June 2016
- 09:00
- What happens when you thermostabilise a GPCR? Bernadette Byrne, Imperial College London, UK
- 09:40
- Rationalising activity cliffs at the adenosine A2a receptor via crystallography Zara Sands, UCB, Belgium
- 10:15
- Refreshments
- 10:45
- Mas-1 receptor inverse agonists for cardiovascular disease Graeme Semple, Arena Pharmaceuticals, UK
- 11:20
- To be confirmed
- 12:00
- Closing remarks David Miller, Takeda Cambridge, U
- 12:05
- Close
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
Fees
Earlybird fees - by 9 March 2016
GB£360 . . . . . . . . . .SCI/RSC Member
GB£440. . . . . . . . . . Non-member
GB£150 . . . . . . . . . .SCI/RSC Student Member
GB£190 . . . . . . . . . .Non-member Student
Standard fees - between 10 March and 11 May 2016
GB£420 . . . . . . . . . .SCI/RSC Member
GB£500 . . . . . . . . . Non-member
GB£170 . . . . . . . . . .SCI/RSC Student Member
GB£215 . . . . . . . . . .Non-member Student
* Student is undergraduate or post-graduate, not post-doc
Exhibition stands are available, priced at:
GB£1,100 . . . . . . . . . . Exhibition stand including one full delegate
GB£1,450 . . . . . . . . . . Exhibition stand including two full delegates
Late fees - for payments received from 12th May onwards
GB£30 Late payment fee will be added to the above standard rates
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
Booking terms and conditions
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Additional Info
Accommodation and Conference Dinner
Some bedrooms have been held at a number of hotels in the city centre. Please download this list.
For all other accommodation requests (including last-minute bookings), we suggest you use the 24-hour service provided by Verona Booking.
The conference registration fee includes two dinners, and you are asked to opt in at time of registration:
- Monday - a vineyard visit to the Cantina Sociale di Soave (Soave and Valpolicella) followed by dinner.
- Tuesday - conference dinner at Aptuit.